Blocking MUC1 can improve the sensitivity of ovarian cancer cells to paclitaxel and doxorubicin [12], as the anti-apoptotic effects of MUC1 on oxidative stress-induced apoptosis [13,14] and genotoxic agent-induced apoptosis [13,15,16] have been correlated to its chemoresistant mechanisms. This evidence concerns the gene MUC1 and ovarian carcinoma.